Literature DB >> 26235051

Response to 'Tacrolimus pharmacokinetics after kidney transplantation--Influence of changes in haematocrit and steroid dose'.

Thomas Vanhove1, Hylke de Jonge1, Henriëtte de Loor2, Kristin Verbeke3, Dirk R J Kuypers1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26235051      PMCID： PMC4693491          DOI： 10.1111/bcp.12728

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  6 in total

1.  Response to 'Tacrolimus pharmacokinetics after kidney transplantation--Influence of changes in haematocrit and steroid dose'.

Authors:  Thomas Vanhove; Hylke de Jonge; Henriëtte de Loor; Kristin Verbeke; Dirk R J Kuypers
Journal:  Br J Clin Pharmacol       Date:  2015-09-15       Impact factor: 4.335

2.  Influence of the CYP3A5 genotype on tacrolimus pharmacokinetics and pharmacodynamics in young kidney transplant recipients.

Authors:  Mariano Ferraresso; Amedea Tirelli; Luciana Ghio; Paolo Grillo; Valentina Martina; Erminio Torresani; Alberto Edefonti
Journal:  Pediatr Transplant       Date:  2007-05

3.  Progressive decline in tacrolimus clearance after renal transplantation is partially explained by decreasing CYP3A4 activity and increasing haematocrit.

Authors:  Hylke de Jonge; Thomas Vanhove; Henriëtte de Loor; Kristin Verbeke; Dirk R J Kuypers
Journal:  Br J Clin Pharmacol       Date:  2015-08-03       Impact factor: 4.335

4.  CYP3A5 and CYP3A4 but not MDR1 single-nucleotide polymorphisms determine long-term tacrolimus disposition and drug-related nephrotoxicity in renal recipients.

Authors:  D R J Kuypers; H de Jonge; M Naesens; E Lerut; K Verbeke; Y Vanrenterghem
Journal:  Clin Pharmacol Ther       Date:  2007-05-09       Impact factor: 6.875

5.  CYP3A5 genotype is not associated with a higher risk of acute rejection in tacrolimus-treated renal transplant recipients.

Authors:  Dennis A Hesselink; Ron H N van Schaik; Madelon van Agteren; Johannes W de Fijter; Anders Hartmann; Martin Zeier; Klemens Budde; Dirk R J Kuypers; Przemyslav Pisarski; Yann Le Meur; Richard D Mamelok; Teun van Gelder
Journal:  Pharmacogenet Genomics       Date:  2008-04       Impact factor: 2.089

6.  Improved prediction of tacrolimus concentrations early after kidney transplantation using theory-based pharmacokinetic modelling.

Authors:  Elisabet Størset; Nick Holford; Stefanie Hennig; Troels K Bergmann; Stein Bergan; Sara Bremer; Anders Åsberg; Karsten Midtvedt; Christine E Staatz
Journal:  Br J Clin Pharmacol       Date:  2014-09       Impact factor: 4.335
  6 in total
  1 in total

1.  Response to 'Tacrolimus pharmacokinetics after kidney transplantation--Influence of changes in haematocrit and steroid dose'.

Authors:  Thomas Vanhove; Hylke de Jonge; Henriëtte de Loor; Kristin Verbeke; Dirk R J Kuypers
Journal:  Br J Clin Pharmacol       Date:  2015-09-15       Impact factor: 4.335
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.